| 608658 |
BMJ OPEN |
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities |
2020-11-01 |
10.1136/bmjopen-2020-039208 |
Lonchampt Sophie, Gerber Fabienne, Aubry Jean-Michel, Desmeules Jules, Besson Marie, Markus Kosel |
| 608657 |
BMJ OPEN |
Understanding the underlying drivers of obesity in Africa: a scoping review protocol |
2020-11-01 |
10.1136/bmjopen-2020-040940 |
Jaca Anelisa, Iwu Chinwe, Durão Solange, Onyango Adelheid W, Wiysonge Charles Shey |
| 608656 |
ONCOTARGETS AND THERAPY |
Next-Generation Sequencing of Synchronous Multiple Primary Lung Cancers in a Patient with Squamous Cell Carcinoma and Small Cell Lung Cancer |
2020-11-01 |
10.2147/ott.s274329 |
Wu Xinggang, Huang Wenhua, Geng Tao, Wei Yutao |
| 608655 |
FUSION ENGINEERING AND DESIGN |
Ultrasonic test results before and after high heat flux testing on W-monoblock mock-ups of EU-DEMO vertical target | Ultrasonic test results before and after high heat flux testing on W-monoblock mock-ups of EU-DEMO vertical target |
2020-11-01 |
10.1016/j.fusengdes.2020.111886 |
Roccella S., Dose G., Barrett T., Cacciotti E., Dupont L., Gallay F., Greuner H., Richou M., Tatì A., Visca E., You J.-H. |
| 608654 |
NEURO-ONCOLOGY |
TMOD-05. EXTRACRANIAL TUMORS INFLUENCE INTRACRANIAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN PRE-CLINICAL MODELS OF MELANOMA BRAIN METASTASIS | TMOD-05. EXTRACRANIAL TUMORS INFLUENCE INTRACRANIAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN PRE-CLINICAL |
2020-11-01 |
10.1093/neuonc/noaa215.956 |
Nayyar Naema, Singh Mohini, Stocking Jackson, Brehm Michael, Brastianos Priscilla |
| 608653 |
NEURO-ONCOLOGY |
NCMP-08. EFFICACY OF ANTIEPILEPTIC DRUGS IN GLIOMA PATIENTS WITH EPILEPSY: A SYSTEMATIC REVIEW | NCMP-08. EFFICACY OF ANTIEPILEPTIC DRUGS IN GLIOMA PATIENTS WITH EPILEPSY: A SYSTEMATIC REVIEW |
2020-11-01 |
10.1093/neuonc/noaa215.520 |
de Bruin Marjolein, van der Meer Pim, Dirven Linda, Taphoorn Martin, Koekkoek Johan |
| 608652 |
NEURO-ONCOLOGY |
CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS | CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS |
2020-11-01 |
10.1093/neuonc/noaa215.166 |
Reardon David, Molinaro Annette, Peters Katherine, Clarke Jennifer, Jordan Justin, de Groot John, Nghiemphu Phioanh, Kaley Thomas, Colman Howard, McCluskey Christine, Smith Timothy, Cote David, Severgnini Mariano, Yearley Jennifer, Zhao Qing, Blumenschein Wendy, Duda Gabriel, Muzikansky Alona, Jain Rakesh, Wen Patrick, Nayak Lakshmi |
| 608651 |
NEURO-ONCOLOGY |
CBIO-21. H3F3A G34R/V MUTATIONS INDUCE CHROMOSOMAL INSTABILITY AND PROMOTE PEDIATRIC HIGH-GRADE GLIOMA FORMATION | CBIO-21. H3F3A G34R/V MUTATIONS INDUCE CHROMOSOMAL INSTABILITY AND PROMOTE PEDIATRIC HIGH-GRADE GLIOMA FORMATION |
2020-11-01 |
10.1093/neuonc/noaa215.081 |
Day Charles, Grigore Florina, Langfald Alyssa, Robinson James, Hinchcliffe Edward |
| 608650 |
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY: JOURNAL OF GREATPOLAND CANCER CENTER IN POZNÁN AND POLISH SOCIETY OF RADIATION ONCOLOGY |
Prospective validation of a core curriculum progress assimilation instrument for radiation oncology residentship |
2020-11-01 |
10.1016/j.rpor.2020.09.003 |
Mauro Geovanne Pedro, Najas Gabriel Faria, Carvalho Heloisa de Andrade, Villar Rosangela Correa |
| 608649 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy |
2020-11-01 |
10.1136/jitc-2020-000960 |
Qin Yong, Bollin Kathryn, de Macedo Mariana Petaccia, Carapeto Fernando, Kim Kevin B, Roszik Jason, Wani Khalida M, Reuben Alexandre, Reddy Sujan T, Williams Michelle D, Tetzlaff Michael T, Wang Wei-Lien, Gombos Dan S, Esmaeli Bita, Lazar Alexander J, Hwu Patrick, Patel Sapna P |
